UPDATED: Covid-fattened shares crash as FDA puts a late-stage coronavirus vaccine trial on hold –

After seeing its market cap soar on the prospects of a highly-touted Covid-19 vaccine, Inovio saw its share price $INO led to slaughter on Monday after announcing that the FDA is forcing investigators to hit the brakes on a planned Phase II/III study. The agency has some questions for Inovio

Sourced through Scoop.it from: endpts.com